The Pharma Data

AUGUST 6, 2020

It signed a manufacturing and distribution agreement with R-Pharm in Russia and tapped the Serum Institute of India to provide for low-income countries. The country is its second-largest market, behind the U.S., Before the BioKangtai tie-up, it promised to provide the U.S. 300 million doses, the EU 300 million doses, the U.K.

Vaccination 52

Vaccination Vaccine Antibody Licensing 52

Delveinsight

JULY 21, 2021

As per the DelveInsight, the therapeutic dynamics of Rheumatoid Arthritis is anticipated to change in the coming years owing to the increase in investment and the R&D activities by key pharma companies like GlaxoSmithKline, Taisho Pharmaceutical, and R-Pharm, who have their key candidates in the late clinical-stage of development.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

Pharmaceutical Technology

JULY 4, 2022

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. We continue to prioritise critical healthcare-related deliveries and operations in these countries to limit any potential patient impact.

Pharma Production 305

Pharma Production Production Clinical Trials Clinical Trials 305

Intouch Solutions

FEBRUARY 23, 2023

A 2021 Accenture survey of 12,000 patients in six countries found that only 16% were aware of a patient service offered to them by a brand. This mirrored what we saw in our survey. Patients named copay cards as the main tool that they’d be interested in seeing from pharma if it became difficult for them to afford their medicine. “The

Marketing 52

Marketing Branding Life Science Clinical Trials 52

Intouch Solutions

FEBRUARY 23, 2023

A 2021 Accenture survey of 12,000 patients in six countries found that only 16% were aware of a patient service offered to them by a brand. This mirrored what we saw in our survey. Patients named copay cards as the main tool that they’d be interested in seeing from pharma if it became difficult for them to afford their medicine. “The

Marketing 52

Marketing Branding Life Science Clinical Trials 52

Delveinsight

JULY 28, 2021

At present some of the key companies such as GlaxoSmithKline, Taisho Pharmaceutical, and R-Pharm have their key candidates in the late clinical stage of development. In addition to these, other players such as Pfizer, Roche, AstraZeneca, and several others are also investigating their candidates.

Marketing 98

Marketing Development Drugs Pharma Companies 98

Advarra

JULY 19, 2022

Q: Can you ship a drug from another country to the U.S. A: The answer is derived from nonclinical pharm/tox studies in animals. While there are courses and even degrees in regulatory affairs, hands-on experience will teach you general topics. A: No, this is not allowed. while the IND is in review?

Packaging 52

Packaging Packaging Drugs Containment 52

The Pharma Data

SEPTEMBER 7, 2020

Adv Studies Pharm. Throughout MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting, Novartis will host dedicated content on Facebook, Twitter and LinkedIn. Immune cell profiles and clinical and safety outcomes with fingolimod in the 12 month FLUENT study of patients with relapsing multiple sclerosis. Multiple sclerosis: a primer and update.

Trials 52

Trials Clinical Trials Clinical Trials Containment 52

The Pharma Data

AUGUST 5, 2020

The studies were conducted in over 350 sites in 37 countries 9. Adv Studies Pharm. The ASCLEPIOS I and II studies enrolled 1882 patients with MS, between the ages of 18 and 55 years, with an Expanded Disability Status Scale (EDSS) score between 0 and 5.5 Ofatumumab demonstrated a significant reduction in ARR by 51% (0.11

Trials 52

Trials Medicine Production Containment 52

Delveinsight

DECEMBER 2, 2020

Apart from this, among the EU5 countries, the highest number of prevalent Cases of Rheumatoid Arthritis was in Germany (in the year 2017). As per the WHO, it is more common in women and in developed countries. The United States, in 2017, accounted for the highest number of cases in the 7MM, i.e., 1,333,290 prevalent cases.

Marketing 60

Marketing Hormones Antibody Development 60

Pharmaceutical Technology

MARCH 15, 2023

The biopharmaceutical company Pharming Group , based in the Netherlands, which develops innovative protein replacement therapies and precision medicines for multiple rare diseases, stated the HSBC acquisition of Silicon Valley Bank UK would allow it access to its $19m deposit and not bear any losses.

Life Science 147

Life Science Development Marketing Medicine 147

Pharmaceutical Technology

JANUARY 6, 2023

However, the Chinese generics manufacturer HEC Pharm argued that the drug’s patent was not properly described in the documents and thus prevented the company from selling its own generic version of Gilenya before the patent expired. Gilenya is an oral medication for multiple sclerosis. Evaluate the effects of COVID-19 on the sector.

Doctors 242

Doctors Doctor Drugs Sales 242